zemprocitinib   Click here for help

GtoPdb Ligand ID: 13221

Synonyms: compound 1 [US20220009927]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: The chemical structure for zemprocitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential. There is a structure match for zemprocitinib in patent US20220009927 (Lynk Pharmaceuticals) [1]. We suspect that zemprocitinib may be Lynk's lead JAK1 inhibitor LNK01001, but this association has not been formally disclosed.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 94.54
Molecular weight 345.42
XLogP 1.24
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCS(=O)(=O)NC12CC(C1)(C2)N3C=NC4=CN=C5C(=C43)C=CN5
Isomeric SMILES N1(C=NC=2C1=C3C(=NC2)NC=C3)C45CC(C4)(C5)NS(=O)(=O)CCC
InChI InChI=1S/C16H19N5O2S/c1-2-5-24(22,23)20-15-7-16(8-15,9-15)21-10-19-12-6-18-14-11(13(12)21)3-4-17-14/h3-4,6,10,20H,2,5,7-9H2,1H3,(H,17,18)
InChI Key WBKCMWRKRQABQF-UHFFFAOYSA-N
Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel